Melissa Barousse Hall (Melissa Hall)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Immune Response

End Stage Renal Disease

Top Venues

Science advances

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)
Taylor Q Nguyen, Gabriela Schneider, Alagammai Kaliappan, Robert Buscaglia, Guy N Brock, Melissa Barousse Hall, Donald M Miller, Jason A Chesney, Nichola C Garbett
Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma Patients. Current oncology (Toronto, Ont.) 30 (7) (2023)
Omar S Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C Chew, Bryce Stamp, Xiang Zhang, Aaron Whitt, Chi Li, Melissa Barousse Hall, Robert A Mitchell, Alfred Zippelius, John Eaton, Jason A Chesney, Kavitha Yaddanapudi
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy. Science advances 9 (26) (2023)